When it comes to treating your patients with diabetes, there are major areas of focus that all healthcare providers should know. While emerging treatment methods are a big topic of discussion, including new medications and their cardiorenal effects, and the broadening implementation of telehealth appointments, there are also core issues that are as important as ever, including the prevention and detection of diabetes complications and addressing poor glycemic control. Drs. Edelman and Pettus, along with a lively panel of diabetes experts—unique to each discussion–are taking a deep dive into the most important and impactful diabetes treatment strategies, drawing on their real-life experience to help you help your patients better manage their diabetes.
MARCH 25, 2021
Prevention, Early Detection and Aggressive Management of CAD and CKD
AN IMMERSIVE DISCUSSION WITH THE EXPERTS
Healthcare professionals who participate in the Making the Connection Deep Dive Series will…
Get a first-hand look at in-depth discussions covering the major areas of modern diabetes treatment
Hear from a diverse faculty with real experience in implementing these modern practices
Have the opportunity to ask experts questions live about each of the topics and their real-world applications
Earn continuing education credit for each program
Receive complimentary registration for each program
Who Can Benefit Most From This Program:
This course is designed for diabetes healthcare providers including endocrinologists, primary care physicians, nurse practitioners, physician assistants, nurses, certified diabetes educators, pharmacists, registered dieticians, and other healthcare providers wanting to expand their knowledge of diabetes management.
INFORMATIONAL AND ENGAGING FORMAT
To allow for a comprehensive discussion of each topic area, each program will consist of a 90-minute virtual session including:
• Live discussion between expert panelists taking an in-depth look at the specific topic related to diabetes treatment
• At least 15 minutes of live Q&A for participants to ask questions about the discussion and the real-world application of the topics discussed
At course completion, participants should be able to:
- Identify the different pathophysiologic defects associated with type 2 diabetes and how all the pharmacologic agents (oral and injectable) address these specific abnormalities.
- Discuss the recently published cardiovascular-renal outcome trials on oral (SGLT2 inhibitors) and injectable type 2 medications (GLP1-RAS).
- Evaluate the use of SGLT-2 and GLP-1 RA in patients who have cardiovascular risks factors and are at risk or have a history of atherosclerotic cardiovascular disease (ASCVD).
- Discuss approaches to combination therapy with the currently available oral agents, as well as physician and patient-directed insulin titration strategies and the basal-bolus approach.
- Design a treatment plan for multiple daily injection regimens and insulin pump therapy including hybrid closed loop systems.
- Demonstrate the ability to select effective therapeutic adjustments based on CGM trending or rate of change arrows, time in range, and standard deviation. Recognize the physical and emotional barriers that prevent patients with diabetes from being persistent and adherent to their therapeutic regimen(s).
- Employ innovative and dynamic strategies for communication with patients to strengthen provider-patient relations and improve patient outcomes.
AMA: Physicians and healthcare providers who participate in this activity may be awarded up to 1.50 AMA PRA Category 1 credits TM.
Nurses: For the purposes of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 creditsTM issued by organizations accredited by the ACCME. For the purpose of re-licensure, the California Board of Registered Nursing accepts AMA PRA Category 1 credits TM
Physician Assistants: The AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 credits TM from organizations accredited for ACCME or a recognized state medical society.
Certified Diabetes Care and Education Specialists: The University of California San Diego is accredited by the ACCME, which is on the NCBDE list of approved providers.
Global Education Group designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number – 0530-9999-21-015-L01-P)
This is a knowledge based activity.
Attention HCPs from outside of the US: To see if you are eligible to receive CME credits check here.
Cultural and Linguistic Competency
This activity is in compliance with California Assembly Bill 1195 which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills that enables health care professionals or organizations to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient’s primary language. Cultural and linguistic competency was incorporated into the planning of this activity. Additional resources can be found on the UC San Diego CME website.
Acknowledgement of Commercial Support
This activity is supported by educational grants from:
Merck Sharp & Dohme Cor
This activity is jointly provided by Taking Control Of Your Diabetes, UC San Diego School of Medicine, and Global Education Group.